首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >A novel approach for the preparation of highly loaded polymeric controlled release dosage forms of diltiazem HCl and diclofenac sodium.
【24h】

A novel approach for the preparation of highly loaded polymeric controlled release dosage forms of diltiazem HCl and diclofenac sodium.

机译:一种制备盐酸地尔硫卓和双氯芬酸钠的高负荷聚合物控释剂型的新方法。

获取原文
获取原文并翻译 | 示例
           

摘要

In this investigation, modified-release dosage forms of diltiazem HCl (DT) and diclofenac sodium (DS) were prepared. The development work comprised two main parts: (a) loading the drug into ethylene vinyl acetate (EVA) polymer, and (b) generation of a non-uniform concentration distribution of the drug within the polymer matrix. Phase separation technique was successfully used to load DT and DS into the polymer at significantly high levels, up to 81 and 76%, respectively. Size diameter of the resultant microspheres was between 1.6 and 2.0mm. Controlled-extraction of loaded microspheres and high vacuum freeze-drying were used to generate the non-uniform concentration distribution and to immobilize the new drug distribution within the matrix. Parameters controlling the different processes were investigated, and hence optimal processing conditions were used to prepare the dosage forms. Rates of drug release from the two dosage forms in water and in media having different pH were found to be constant for anappreciable length of time (>8h) followed by a slow decline; a characteristic of a non-Fickian diffusion process. Scanning electron microscopy studies suggested that the resultant release behavior was the outcome of the combined effects of the non-uniform distribution of the drug in the matrix and the apparent changes in the pores and surface characteristics of the microspheres. Comparison of release rate-time plots of dissolution data of marketed products with the newly developed dosage forms indicated the ability of the latter to sustain more zero order release.
机译:在这项研究中,制备了盐酸地尔硫卓(DT)和双氯芬酸钠(DS)的调释剂型。开发工作包括两个主要部分:(a)将药物加载到乙烯乙酸乙烯酯(EVA)聚合物中,以及(b)药物在聚合物基质中的浓度分布不均匀。相分离技术已成功用于将DT和DS分别以高达81%和76%的高含量加载到聚合物中。所得微球的尺寸直径在1.6至2.0mm之间。负载微球的控制萃取和高真空冷冻干燥被用于产生浓度不均匀的分布,并将新药物分布固定在基质中。研究了控制不同过程的参数,因此使用了最佳加工条件来制备剂型。发现在水和pH值不同的介质中,两种剂型的药物释放速率在一段可观的时间长度(> 8h)内保持恒定,然后缓慢下降。非菲克扩散过程的特征。扫描电子显微镜研究表明,最终的释放行为是药物在基质中分布不均匀以及微球的孔和表面特性发生明显变化的综合结果。市场产品与新开发的剂型的溶出度数据的释放速率-时间图的比较表明,后者具有维持更多零级释放的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号